Rare diseases
Investigational molecules
Locations
Back to Italy2 684 clinical trials in Novara, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)A study to test if BHV-8000 is effective and safe for adults with early Parkinson's disease
ItalyStudy of N-803, tislelizumab and docetaxel combination versus docetaxel alone for patients with advanced or metastatic non-small cell lung cancer resistant to immune checkpoint inhibitors
ItalyStudy of olpasiran to prevent first major cardiovascular events in people with high levels of lipoprotein(a)
ItalyEfficacy and Safety Study of Paltusotine for Adults with Carcinoid Syndrome due to Well-Differentiated Neuroendocrine Tumors
ItalyStudy of Amlitelimab and BI 1015550 for Patients with Interstitial Lung Disease Due to Scleroderma
ItalyStudy on the Effectiveness of JNJ-77242113 and Deucravacitinib for Treating Moderate to Severe Plaque Psoriasis in Adults
ItalyStudy on ABCB5+ MSCs for Recessive Dystrophic and Junctional Epidermolysis Bullosa Patients
ItalyStudy on Rocatinlimab for Adolescents Aged 12-17 with Moderate-to-Severe Atopic Dermatitis
ItalyStudy of LY3454738 for Treating Moderate-to-Severe Atopic Dermatitis in Adults
ItalySaroglitazar hemimagnesium normalizes alkaline phosphatase in primary biliary cholangitis patients with incomplete response or intolerance to ursodeoxycholic acid
ItalyPhase 3 Study of trastuzumab brengitecan versus platinum‑based chemotherapy in adults with HER2‑positive metastatic urothelial cancer after anti‑PD‑(L)1 therapy
ItalyPhase 2 Study of Apitegromab in Patients with Facioscapulohumeral Muscular Dystrophy
ItalyThe busiest research cities in the country
What the registry says about research in the country
Clinical trials focusing on hematologic malignancies and solid tumors, investigating innovative treatments for various cancer types including leukemia, breast cancer, and lung cancer.
Studies evaluating combination therapies and targeted treatments to improve patient outcomes.
Research focusing on heart failure prevention and treatment strategies, particularly exploring new drug combinations and their impact on cardiovascular outcomes.
Innovative approaches combining multiple therapeutic agents to address cardiovascular risks.
Investigations into treatments for various autoimmune disorders, including Sjögren's Syndrome and rheumatoid arthritis, with emphasis on novel therapeutic approaches.
Focus on developing targeted therapies for better disease management and patient care.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
